Thrombosis News and Research

Latest Thrombosis News and Research

Researchers find a potentially game-changing blood clot treatment

A potentially game-changing treatment for people with, or at risk of, blood clots has been found effective by an international team of researchers led by McMaster University's Jeffrey Weitz.

19 Jul 2021

Preventing lethal blood clots

In our latest interview, we spoke to Professor Robert Ariëns from the University of Leeds about his latest research into blood clots and how they can be prevented.

19 Jul 2021

Imaging technology may be able to treat life-threatening blood clotting condition

Penn State College of Engineering researchers set out to develop technology capable of localizing and imaging blood clots in deep veins. Turns out their work may not only identify blood clots, but it may also be able to treat them.

15 Jul 2021

Could aspirin intake reduce mortality risk in COVID-19 patients?

Scientists from the Michigan State University, USA, have conducted a systematic review and meta-analysis to compare mortality rate in coronavirus disease 2019 (COVID-19) patients who are aspirin users or non-users. The Findings reveal that the use of aspirin is associated with a significant reduction in overall and in-hospital mortality rates.

13 Jul 2021

Striking increase in SARS-CoV-2 antibodies seen with prime dose AstraZeneca vaccine followed by Pfizer-BioNTech

Researchers in Germany have provided evidence that a booster shot of a messenger RNA (mRNA)-based coronavirus disease 2019 (COVID-19) vaccine following prime immunization with AstraZeneca’s adenoviral vector-based vaccine is sufficient to achieve high levels of neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

8 Jul 2021

Angiotensin II type 1 receptor-targeting autoantibodies may increase COVID-19 severity

A team of US-based scientists recently demonstrated that pro-thrombotic autoantibodies that target angiotensin II type 1 receptor (AT1R) may be associated with endothelial complications observed in coronavirus disease 2019 (COVID-19), a novel disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Jul 2021

High levels of neutrophil extracellular traps found in airways of severely ill Covid-19 patients

When researchers at Lund University in Sweden performed advanced analyses of sputum from the airways of severely ill Covid-19 patients, they found high levels of neutrophil extracellular traps (NETs).

1 Jul 2021

Findings suggest that the cross-linking of fibrin proteins is key to reducing blood clot formation

Researchers have found that the y cross-chain structure of fibrin proteins is essential to stabilizing blood clots that can lead to harmful embolism formation.

29 Jun 2021

A new guide for cancer-associated thrombosis

Ever since the association between cancer and thrombosis was reported by Jean-Baptiste Bouillaud in the early 19th century, cancer-associated thrombosis has remained a challenging domain of cancer management.

24 Jun 2021

New research identifies a link between the gut microbiome and strokes

A recent study demonstrates the impact of diets that are high in choline and trimethylamine on increasing stroke severity and functional deficits.

21 Jun 2021

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

A new study, released as a preprint on bioRxiv* server, shows that a combination of the biological interferon-α and the small molecule nafamostat are effective against SARS-CoV-2 infection in vitro, as well as in vivo.

18 Jun 2021

Study details the treatment of COVID-19 vaccine-associated myocarditis-like illness in 7 patients

Findings from a small study detailing the treatment of myocarditis-like symptoms in seven people after receiving a COVID-19 vaccine in the U.S. are published today in the American Heart Association’s flagship journal Circulation.

17 Jun 2021

Research provides insights into why COVID-19 patients develop severe blood clots

Scientists have identified how and why some Covid-19 patients can develop life-threatening clots, which could lead to targeted therapies that prevent this from happening.

15 Jun 2021

Joint ICMRA and WHO statement explains how COVID-19 vaccines are regulated for safety, effectiveness

Healthcare professionals and public health authorities have a central role in discussing vaccination against COVID-19 with their patients.

13 Jun 2021

Researchers devise new way to design clot-prone grafts for dialysis

People with end-stage renal disease often undergo hemodialysis, a life-sustaining blood-filtering treatment.

11 Jun 2021

Has COVID-19 vaccine confidence dropped following the pause of Johnson & Johnson/Janssen?

A new study, which was conducted by Vishala Mishra and Joseph P. Dexter at Madras Medical College, Chennai, India, suggests that the infamous pause in the administration of the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine, advised by the FDA, has left doubt about the veracity of vaccine safety claims. This is a development that may have engendered vaccine hesitancy in a segment of the population.

11 Jun 2021

NCCN experts provide new guidance on COVID-19 vaccines for cancer patients

The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert review of evolving evidence.

11 Jun 2021

Thrombosis News and Research

Latest Thrombosis News and Research

Researchers find a potentially game-changing blood clot treatment

Preventing lethal blood clots

Imaging technology may be able to treat life-threatening blood clotting condition

Could aspirin intake reduce mortality risk in COVID-19 patients?

Striking increase in SARS-CoV-2 antibodies seen with prime dose AstraZeneca vaccine followed by Pfizer-BioNTech

Angiotensin II type 1 receptor-targeting autoantibodies may increase COVID-19 severity

High levels of neutrophil extracellular traps found in airways of severely ill Covid-19 patients

Findings suggest that the cross-linking of fibrin proteins is key to reducing blood clot formation

A new guide for cancer-associated thrombosis

New research identifies a link between the gut microbiome and strokes

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

Study details the treatment of COVID-19 vaccine-associated myocarditis-like illness in 7 patients

Research provides insights into why COVID-19 patients develop severe blood clots

Joint ICMRA and WHO statement explains how COVID-19 vaccines are regulated for safety, effectiveness

Researchers devise new way to design clot-prone grafts for dialysis

Has COVID-19 vaccine confidence dropped following the pause of Johnson & Johnson/Janssen?

NCCN experts provide new guidance on COVID-19 vaccines for cancer patients

New cell-penetrating peptide may protect against life-threatening microbial inflammation

Research suggests low platelet counts may be associated with Oxford-AstraZeneca vaccine

AI could predict treatment demand for chronic eye diseases

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Thrombosis News and Research

Latest Thrombosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in